SINGLE-DOSE KINETICS AND BIOAVAILABILITY OF KETOBEMIDONE

被引:10
作者
ANDERSON, P
ARNER, S
BONDESSON, U
BOREUS, LO
HARTVIG, P
机构
[1] KAROLINSKA HOSP,DEPT ANAESTHESIOL,S-10401 STOCKHOLM 60,SWEDEN
[2] UNIV UPPSALA HOSP,HOSP PHARM,S-75014 UPPSALA,SWEDEN
[3] NATL BOARD HLTH & WELF,DEPT DRUGS,UPPSALA,SWEDEN
关键词
D O I
10.1111/j.1399-6576.1982.tb01848.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:59 / 62
页数:4
相关论文
共 13 条
[1]   CLINICAL PHARMACOKINETICS OF KETOBEMIDONE - ITS BIOAVAILABILITY AFTER RECTAL ADMINISTRATION [J].
ANDERSON, P ;
ARNER, S ;
BONDESSON, U ;
BOREUS, LO ;
HARTVIG, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (03) :217-223
[2]  
BERKOWITZ BA, 1975, CLIN PHARMACOL THER, V17, P629
[3]   MASS FRAGMENTOGRAPHIC METHOD FOR THE DETERMINATION OF KETOBEMIDONE IN PLASMA [J].
BONDESSON, U ;
HARTVIG, P .
JOURNAL OF CHROMATOGRAPHY, 1979, 179 (01) :207-212
[4]   CLINICAL PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF KETOBEMIDONE [J].
BONDESSON, U ;
ARNER, S ;
ANDERSON, P ;
BOREUS, LO ;
HARTVIG, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (01) :45-50
[6]  
BRUNK SF, 1974, CLIN PHARMACOL THER, V16, P51
[7]  
DEBOER AG, 1979, CLIN PHARMACOL THER, V26, P701
[8]  
EDDY N B, 1957, Bull World Health Organ, V17, P569
[9]  
LIESSEM H, 1951, Munch Med Wochenschr, V93, P604
[10]  
MOOLENAAR F, 1980, PHARM INT, V1, P144